Literature DB >> 8281143

The human homolog of the glomerulosclerosis gene Mpv17: structure and genomic organization.

M Karasawa1, R M Zwacka, A Reuter, T Fink, C L Hsieh, P Lichter, U Francke, H Weiher.   

Abstract

Mice carrying a retroviral insert in both alleles of the Mpv17 gene develop glomerulosclerosis and nephrotic syndrome at young age. Thus, the Mpv17 gene is a recessive disease gene in mice and this mouse strain is a potential animal model for glomerular diseases in man. We here describe the isolation and analysis of a human homolog of this gene. By interspecies hybridisation cDNA clones representing a single RNA species were isolated from human liver. Sequence analysis revealed over 90% identify in a region coding for a protein of 176 amino acids and unknown function in both species. Cloning of the genomic locus revealed a single copy gene which we mapped to the short arm of chromosome 2 at band 2p23-p21. Determination of the intron-exon structure and the junction sequences enabled us to establish a PCR based procedure to isolate the coding region from human genomic DNA. Thus, it is now possible to analyse patients suffering from candidate diseases on the basis of a blood sample if biopsy material is not available.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8281143     DOI: 10.1093/hmg/2.11.1829

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  9 in total

1.  Inner ear defect similar to Alport's syndrome in the glomerulosclerosis mouse model Mpv17.

Authors:  A M Meyer zum Gottesberge; A Reuter; H Weiher
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

2.  Arabidopsis AtMPV17, a homolog of mice MPV17, enhances osmotic stress tolerance.

Authors:  Jiwoong Wi; Yeonju Na; Eunju Yang; Jung-Hyun Lee; Won-Joong Jeong; Dong-Woog Choi
Journal:  Physiol Mol Biol Plants       Date:  2020-06-13

3.  Glomerular overproduction of oxygen radicals in Mpv17 gene-inactivated mice causes podocyte foot process flattening and proteinuria: A model of steroid-resistant nephrosis sensitive to radical scavenger therapy.

Authors:  C J Binder; H Weiher; M Exner; D Kerjaschki
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

4.  MPV17 Mutations Causing Adult-Onset Multisystemic Disorder With Multiple Mitochondrial DNA Deletions.

Authors:  Caterina Garone; Juan Carlos Rubio; Sarah E Calvo; Ali Naini; Kurenai Tanji; Salvatore Dimauro; Vamsi K Mootha; Michio Hirano
Journal:  Arch Neurol       Date:  2012-12

5.  A monoclonal antibody raised against bacterially expressed MPV17 sequences shows peroxisomal, endosomal and lysosomal localisation in U2OS cells.

Authors:  Hans Weiher; Haymo Pircher; Pidder Jansen-Dürr; Silke Hegenbarth; Percy Knolle; Silke Grunau; Miia Vapola; J Kalervo Hiltunen; Ralf M Zwacka; Elmon Schmelzer; Kerstin Reumann; Hans Will
Journal:  BMC Res Notes       Date:  2016-02-27

6.  A Yeast-Based Repurposing Approach for the Treatment of Mitochondrial DNA Depletion Syndromes Led to the Identification of Molecules Able to Modulate the dNTP Pool.

Authors:  Giulia di Punzio; Micol Gilberti; Enrico Baruffini; Tiziana Lodi; Claudia Donnini; Cristina Dallabona
Journal:  Int J Mol Sci       Date:  2021-11-12       Impact factor: 5.923

7.  The glomerulosclerosis gene Mpv17 encodes a peroxisomal protein producing reactive oxygen species.

Authors:  R M Zwacka; A Reuter; E Pfaff; J Moll; K Gorgas; M Karasawa; H Weiher
Journal:  EMBO J       Date:  1994-11-01       Impact factor: 11.598

8.  Pathological alleles of MPV17 modeled in the yeast Saccharomyces cerevisiae orthologous gene SYM1 reveal their inability to take part in a high molecular weight complex.

Authors:  Micol Gilberti; Enrico Baruffini; Claudia Donnini; Cristina Dallabona
Journal:  PLoS One       Date:  2018-10-01       Impact factor: 3.240

9.  MPV17 does not control cancer cell proliferation.

Authors:  Morgane Canonne; Anaïs Wanet; Thuy Truong An Nguyen; Alexis Khelfi; Sophie Ayama-Canden; Martine Van Steenbrugge; Antoine Fattaccioli; Etienne Sokal; Mustapha Najimi; Thierry Arnould; Patricia Renard
Journal:  PLoS One       Date:  2020-03-10       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.